Okanoue T - Search Results

1

A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis.

Newsome PN, Buchholtz K, Cusi K, Linder M, Okanoue T, Ratziu V, Sanyal AJ, Sejling AS, Harrison SA; NN9931-4296 Investigators. Newsome PN, et al. Among authors: okanoue t. N Engl J Med. 2021 Mar 25;384(12):1113-1124. doi: 10.1056/NEJMoa2028395. Epub 2020 Nov 13. N Engl J Med. 2021. PMID: 33185364 Clinical Trial.

2

Regulation of hepatocyte albumin and alpha 1-acid glycoprotein secretion by monokines, dexamethasone, and nitric oxide synthase pathway: significance of activated liver nonparenchymal cells.

Itoh Y, Okanoue T, Enjo F, Sakamoto S, Takami S, Yasui K, Kagawa K, Kashima K. Itoh Y, et al. Among authors: okanoue t. Dig Dis Sci. 1994 Apr;39(4):851-60. doi: 10.1007/BF02087433. Dig Dis Sci. 1994. PMID: 7512018

3

[Autoimmune disorders in interferon therapy].

Okanoue T, Itoh Y, Yasui K. Okanoue T, et al. Nihon Rinsho. 1994 Jul;52(7):1924-8. Nihon Rinsho. 1994. PMID: 7521440 Review. Japanese.

4

Serum autoantibody against interleukin-1 alpha is unrelated to the etiology or activity of liver disease but can be raised by interferon treatment.

Itoh Y, Okanoue T, Sakamoto S, Nishioji K, Kashima K, Ohmoto Y. Itoh Y, et al. Among authors: okanoue t. Am J Gastroenterol. 1995 May;90(5):777-82. Am J Gastroenterol. 1995. PMID: 7733087

5

Hemodynamic effects of combined treatment with somatostatin analogue (SMS 201-995) and low-dose isosorbide dinitrate on portal hypertension in conscious cirrhotic rats.

Hori N, Okanoue T, Sawa Y, Itoh Y, Mori T, Takami S, Kashima K. Hori N, et al. Among authors: okanoue t. J Gastroenterol. 1994 Aug;29(4):460-8. doi: 10.1007/BF02361244. J Gastroenterol. 1994. PMID: 7951857

6

Role of sinusoidal endothelial cells in liver disease.

Okanoue T, Mori T, Sakamoto S, Itoh Y. Okanoue T, et al. J Gastroenterol Hepatol. 1995;10 Suppl 1:S35-7. doi: 10.1111/j.1440-1746.1995.tb01794.x. J Gastroenterol Hepatol. 1995. PMID: 8589339

7

[Dysmorphogenesis of intrahepatic bile duct].

Okanoue T, Takami S. Okanoue T, et al. Ryoikibetsu Shokogun Shirizu. 1995;(7):553-4. Ryoikibetsu Shokogun Shirizu. 1995. PMID: 8749552 Review. Japanese. No abstract available.

8

The effects of prednisolone and interferons on serum macrophage colony stimulating factor concentrations in chronic hepatitis B.

Itoh Y, Okanoue T, Sakamoto S, Nishioji K, Kashima K. Itoh Y, et al. Among authors: okanoue t. J Hepatol. 1997 Feb;26(2):244-52. doi: 10.1016/s0168-8278(97)80037-2. J Hepatol. 1997. PMID: 9059942

9

Acute liver damage with characteristic apoptotic hepatocytes by ingestion of Aplysia kurodai, a sea hare.

Sakamoto Y, Nakajima T, Misawa S, Ishikawa H, Itoh Y, Nakashima T, Okanoue T, Kashima K, Tsuji T. Sakamoto Y, et al. Among authors: okanoue t. Intern Med. 1998 Nov;37(11):927-9. doi: 10.2169/internalmedicine.37.927. Intern Med. 1998. PMID: 9868953 Free article.

10

Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: a retrospective study in 1148 patients. Viral Hepatitis Therapy Study Group.

Okanoue T, Itoh Y, Minami M, Sakamoto S, Yasui K, Sakamoto M, Nishioji K, Murakami Y, Kashima K. Okanoue T, et al. J Hepatol. 1999 Apr;30(4):653-9. doi: 10.1016/s0168-8278(99)80196-2. J Hepatol. 1999. PMID: 10207807 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

467 results

Search Page